Royalty Report: Drugs, Biotechnology, Pharmaceuticals – Collection: 6932

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 5

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5

Primary Industries

  • Drugs
  • Biotechnology
  • Pharmaceuticals

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 6932

License Grant
The Company entered into the Columbia License described below. On October 10, 2006, we entered into a contribution Agreement with Sentigen pursuant to which Sentigen transferred to us all of its olfaction intellectual property, including the Columbia License. On October 17, 2006, Columbia consented to the assignment of the Columbia License from Sentigen Biosciences to us subject to certain conditions, all of which have been satisfied to the extent currently required.  As of January 30, 2011 the Columbia License was amended such that the License in the patents originally contained in the Columbia License were terminated and, in consideration for such termination, the royalties payable by the Company to Columbia were reduced.

The Columbia License, as amended, provides us with worldwide rights to certain of Columbia’s rights in the areas of insect chemosensation and olfaction. The Columbia License gives us an exclusive License to develop, manufacture, have made, import, use, sell, distribute, rent or lease any product or service that involves the know-how, confidential information and physical materials conveyed by Columbia to us (collectively, the Licensed Products/Services).

Field of Use
The Field of Use apply to the healthcare industry.

IPSCIO Record ID: 29188

License Grant
On April 10, 2000, the company entered into a License Agreement with the Licensor for an exclusive worldwide right to Licensor’s patent applications and other proprietary rights in the areas of insect chemosensation and olfaction.
Field of Use
The rights granted is relating to the perception of chemical agents, especially in the sense of smell.

IPSCIO Record ID: 26297

License Grant
The April 10, 2000 license agreement provides the Licensee with worldwide rights to certain of the Licensor's patent applications and other rights in the areas of insect chemosensation and olfaction. The Licensee also receives an exclusive license to develop, manufacture, have made, import, use, sell, distribute, rent or lease (i) any product or service the development, manufacture, use, sale, distribution, rental or lease of which is covered by a claim of a patent licensed to them under the agreement or (ii) any product or service that involves the know-how, confidential information and physical materials conveyed by the licensor to licensee relating to the patents licensed.
Field of Use
The rights granted apply to the areas of insect chemosensation and olfaction.

IPSCIO Record ID: 28588

License Grant
The Company and the Columbia wish to amend the Agreement.  Therefore, in consideration of the premises and the mutual covenants herein set forth, the parties hereto hereby agree as follows
Termination of License to Licensed Patents.  The license to Patents granted by Columbia to the Company is hereby terminated as of the Amendment Effective Date.  The Parties further agree that all Licensed Patents shall be returned to Columbia as the exclusive owner thereof, all references to Licensed Patents in the Agreement.
License Property
The Licensee and the University are parties to that certain License Agreement dated April 10, 2000, as amended on October 17, 2006. Licensee has represented to the University that it has executed a Project Research and Product Development Agreement with Bayer CropScience AG effective September 15, 2010.  

Licensed Technical Information  All information and materials originally derived and described in Columbia Invention Report No. 907, now U.S. Application Serial Number 11/825,626 and all foreign equivalents, which includes a method of identifying a compound capable of specifically binding to an insect odorant receptor and a method of identifying a compound capable of activating the activity of an insect odorant receptor.

Field of Use
The Parties agree that know-how and materials derived from Dr. Richard Axel’s laboratory at Columbia using Drosophila sequences and used in the discovery or development of any know how including but not limited to Anopholes species will be treated as Licensed Technical Information.

IPSCIO Record ID: 26674

License Grant
The University grants to the Company, (i) an exclusive license under the licensed Patents to develop, manufacture, have made, import, use, sell, have sold, distribute, rent or lease Licensed Products/Services throughout the Territory, together with a right to grand sublicenses.
License Property
Certain patent applications titled Nucleic Acids and Proteins of Insect or 83b odorant receptor genes and uses thereof.” The olfaction intellectual property assets are also referred to herein as “our olfaction intellectual property.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.